Howard Scher

Scher earned his BS from Bates College and his MD from New York University School of Medicine before doing his residency at Bellevue Hospital.^[2] He married Deborah Ann Lafer in 1989.^[3]

Scher has been an investigator at Memorial Sloan Kettering Cancer Center since 1992 and Professor of Medicine at the Weill Cornell Medical College.^[4] His areas of research include PI3K, the androgen receptor, HSP90, and immunotherapy.

Scher is on the board of directors at Asterias, a biotechnology company.^[5]

Scher was awarded American Association for Cancer Research's 2015 Team Science Award along with Michael E. Jung and Charles Sawyers for their work in the development of enzalutamide.^[6] He has also collaborated with Brett Carver and Neal Rosen, both also at MSKCC, on experimental cancer therapeutics for androgen-resistance prostate cancer.^[7]

Scher has published over 500 scholarly works.